מזומנים למניה אחת chemomab.com (CMMB)

סמל תאגידי ולוגו של Chemomab Therapeutics Ltd. (CMMB)

Chemomab Therapeutics (CMMB) is optimizing costs by utilizing Israeli laboratories and CDMO outsourcing for antibody production. This approach enables the development of partnerships with scientific centers focused on combating fibrosis. The cash per share volume visualizes the financial foundation for such alliances, where 0.92 describes the current status of the metric. The company is currently scaling international Phase 2 trials for the therapy of rare skin and liver pathologies.

chemomab.com (CMMB): מזומנים למניה מ-04.07.2022 עד 20.11.2026

פילוחי מדדים מקיפים ואנליטיקה עבור Chemomab Therapeutics Ltd (CMMB)

- שער מניה ותחזית מחירי מומחים:
- פרטי פוזיציית מזומנים ותזרימי מזומנים:
ניתוח מקיף של החברה:CMMB Chemomab Therapeutics Ltd
סחורת הדגל של Chemomab Therapeutics Ltd.

Developing antibodies for the treatment of orphan pathologies requires colossal capital expenditures for CM-101 clinical trials. This metric determines the amount of liquidity per share, serving as an indicator of financial autonomy. By analyzing the cash per share chart, an investor can see the trend of reserve spending on R&D. A declining line reflects operational activity, while an increase indicates strengthened protection. This is a key solvency criterion for the Chemomab Therapeutics (CMMB) biotech asset.

ניתוח חברות מתחרות